Dr Hwang on Considering AEs Associated With FDA-Approved Agents in Nonmetastatic Prostate Cancer

Clara Hwang, MD, discusses adverse effects associated with FDA-approved agents for patients with nonmetastatic prostate cancer.

Related Keywords

Clara Hwang ,Henry Ford Health System ,Wayne State University School Of Medicine ,Wayne State University School ,Henry Ford Health ,Onclive Tv ,Prostate Cancer ,